Nestle to buy Atrium Innovations for $2.3 billion Business, Consumer Health Care, M&A, Nutrition, Packaged Foods, Probiotics, Vitamins Nestle is buying Canadian vitamin maker Atrium Innovations for $2.3 billion, expanding its presence in consumer healthcare. Read more December 5, 2017/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2017-12-05 13:57:552017-12-06 13:19:10Nestle to buy Atrium Innovations for $2.3 billion
